Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRSN | AMGN | VRTX | GILD | BMY |
| Company | Neurosense Therapeutics Ltd | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.2600 | 320.58 | 473.91 | 89.49 | 54.33 |
| High | 1.3400 | 320.58 | 475.48 | 90.71 | 55.77 |
| Low | 1.1500 | 314.61 | 469.48 | 89.37 | 54.32 |
| Last | 1.2501 | 316.74 | 471.39 | 90.43 | 55.25 |
| Change | -0.0198 | -2.48 | +0.27 | +0.92 | +0.93 |
| % Change | -1.56% | -0.78% | +0.06% | +1.03% | +1.71% |
| Volume | 208,407 | 637,257 | 354,674 | 2,873,188 | 4,946,360 |
| 20-Day Average Volume | 209,441 | 1,645,723 | 1,005,742 | 5,017,326 | 8,442,179 |
| Previous Close | 1.2699 | 319.22 | 471.12 | 89.51 | 54.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1842 | 319.62 | 476.81 | 87.30 | 53.04 |
| 20-Day Raw Stochastic | 80.21% | 32.15% | 42.90% | 95.87% | 77.40% |
| 20-Day Relative Strength | 58.43% | 45.26% | 48.62% | 70.26% | 61.72% |
| Weighted Alpha | +22.94 | +15.40 | +22.59 | +28.08 | +15.80 |
| Today's Opinion | 56% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 56% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.33% since 10/28/24 | -0.18% since 10/28/24 | -0.98% since 10/28/24 | +1.89% since 10/28/24 | +4.66% since 10/28/24 |
| Low | 1.1200 on 10/31/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 86.81 on 10/29/24 | 52.14 on 10/29/24 |
| High | 1.4000 on 10/29/24 | 323.40 on 10/31/24 | 478.06 on 10/29/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | +3.57% since 10/04/24 | -0.96% since 10/04/24 | +3.60% since 10/04/24 | +6.92% since 10/04/24 | +2.10% since 10/04/24 |
| Low | 0.9200 on 10/16/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 1.4000 on 10/29/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | +76.78% since 08/02/24 | -5.21% since 08/02/24 | -4.60% since 08/02/24 | +17.81% since 08/02/24 | +12.97% since 08/02/24 |
| Low | 0.5985 on 08/07/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 1.4550 on 09/16/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | -1.88% since 05/03/24 | +1.70% since 05/03/24 | +17.61% since 05/03/24 | +39.61% since 05/03/24 | +25.24% since 05/03/24 |
| Low | 0.5120 on 07/19/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 1.5000 on 07/02/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,354 | 171,526,160 | 121,597,008 | 111,439,232 | 110,128,096 |
| Shares Outstanding, K | 13,666 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -11,280,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -5,400,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.58 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 06/24/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/26/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.66 | 0.00 | 18.90 | 47.67 |